Primo Biotechnology Co., Ltd., a leading biotech company specializing in the development and manufacturing of radiopharmaceuticals, continues to drive innovation in precision cancer care. With internationally certified facilities and cutting-edge expertise, Primo is committed to advancing molecular imaging and targeted therapy technologies that offer new hope and improved outcomes for cancer patients worldwide.